Issued Patents All Time
Showing 1–25 of 39 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12331110 | Monoclonal antibodies against endotrophin and the use thereof | Ningyan Zhang, Dawei BU, Hui DENG, Philipp E. Scherer | 2025-06-17 |
| 12331130 | DDR1 antibodies and uses thereof | Ningyan Zhang, Hui DENG, Xiujie SUN, Rong Li | 2025-06-17 |
| 12202895 | LILRB4 antibodies and uses thereof | Chengcheng Zhang, Ningyan Zhang, Xun GUI, Mi Deng, Tao Huang +2 more | 2025-01-21 |
| 12152071 | EGFL6 specific monoclonal antibodies and methods of their use | Ningyan Zhang, Anil K. Sood | 2024-11-26 |
| 12084403 | Linkers for antibody drug conjugates | Kyoji TSUCHIKAMA, Yasuaki ANAMI, Chisato TSUCHIKAMA, Ningyang ZHANG | 2024-09-10 |
| 12037390 | Leptin antibodies and method of reducing leptin | Ningyan Zhang, Philipp E. Scherer, Shangang Zhao | 2024-07-16 |
| 11912758 | Methods of treating metastasis, including inhibiting bone cancer metastasis, by administering an antibody which binds connexin 43 (Cx43) hemichannel | Jean X. Jiang, Ningyan Zhang, Wei Xiong, Manuel A. Riquelme, Sumin Gu +1 more | 2024-02-27 |
| 11906519 | Methods for identifying LILRB-blocking antibodies | Chengcheng Zhang, Ningyan Zhang, Mi Deng, Jaehyup Kim, Xun GUI | 2024-02-20 |
| 11760799 | Leptin antibodies | Ningyan Zhang, Philipp E. Scherer, Shangang Zhao | 2023-09-19 |
| 11629122 | Linkers for antibody drug conjugates | Kyoji TSUCHIKAMA, Yasuaki ANAMI, Chisato TSUCHIKAMA, Ningyang ZHANG | 2023-04-18 |
| 11498963 | Anti-LILRB antibodies and their use in detecting and treating cancer | Chengcheng Zhang, Mi Deng, Wei Xiong, Ningyan Zhang, Xun GUI +1 more | 2022-11-15 |
| 11377491 | Anti-leukocyte-associated immunoglobulin-like receptor 1 (LAIR1) monoclonal antibodies and method of use thereof to treat cancer | X. Liao, Qiang Liu, Ningyan Zhang, Xun GUI, Chengcheng Zhang +2 more | 2022-07-05 |
| 11230591 | CMV neutralizing antigen binding proteins | Tong-Ming Fu, Aimin Tang, Dai Wang, Ningyan Zhang, Sha Ha | 2022-01-25 |
| 11174320 | HER3 specific monoclonal antibodies for diagnostic and therapeutic use | Ningyan Zhang | 2021-11-16 |
| 10975142 | Endotrophin neutralization and use thereof | Philipp E. Scherer, Jiyoung Park | 2021-04-13 |
| 10889637 | Methods of treating an osteolytic tumor and spinal cord injury by administering connexin (Cx) 43 hemichannel-binding antibodies | Jean X. Jiang, Ningyan Zhang, Wei Xiong, Manuel A. Riquelme, Sumin Gu +1 more | 2021-01-12 |
| 10875912 | EGFL6 specific monoclonal antibodies and methods of their use | Ningyan Zhang, Anil K. Sood | 2020-12-29 |
| 10501538 | Anti-LILRB antibodies and their use in detecting and treating cancer | Chengcheng Zhang, Mi Deng, Wei Xiong, Ningyan Zhang, Xun GUI +1 more | 2019-12-10 |
| 10358501 | HER3 specific monoclonal antibodies for diagnostic and therapeutic use | Ningyan Zhang | 2019-07-23 |
| 10221235 | Endotrophin neutralization and use thereof | Philipp E. Scherer, Jiyoung Park | 2019-03-05 |
| 10106617 | High affinity antibody antagonists of interleukin-13 receptor alpha 1 | Andrew Donald Nash, Manuel Baca, Louis Jerry Fabri, Dennis Zaller, William Strohl | 2018-10-23 |
| 9868777 | CMV neutralizing antigen binding proteins | Tong-Ming Fu, Dai Wang | 2018-01-16 |
| 9777062 | High affinity antibody antagonists of interleukin-13 receptor alpha 1 | Andrew Donald Nash, Manuel Baca, Louis Jerry Fabri, Dennis Zaller, William Strohl | 2017-10-03 |
| 9725520 | HER3 specific monoclonal antibodies for diagnostic and therapeutic use | Ningyan Zhang | 2017-08-08 |
| 9605057 | Endotrophin neutralization and use thereof | Philipp E. Scherer, Jiyoung Park | 2017-03-28 |